Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 140 pseudogene (RNU7-140P) is a human pseudogene related to the U7 small nuclear RNA (snRNA) family[1]. U7 snRNA is a component of the U7 small nuclear ribonucleoprotein (snRNP) complex, which is essential for the 3' end processing of histone pre-mRNAs, a critical step in histone mRNA maturation[2][3][5]. A pseudogene, however, is a DNA sequence similar to a gene but nonfunctional due to mutations or lack of essential regulatory elements; thus, RNU7-140P does not produce a functional RNA product and has no established biological or disease-associated function[1]. There are no known interactions with drugs, roles as biomarkers, or safety concerns documented for this pseudogene, nor is it considered a therapeutic target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 140 pseudogene (RNU7-140P).